帕金森病中的生物标志物和神经成像标志物
Dongning Su1, Yuanchu Zheng2, Tao Feng1,2
1Center for Movement Disorders, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
Chinese medical journal
|August 29, 2025
概括
通过使用体液中的生物标志物以及MRI,SPECT和PET扫描等先进的神经成像技术, 这些方法为早期发现和更好的治疗策略提供了新的希望.
科学领域:
- 神经科学
- 医疗诊断
- 生物标志物研究
背景情况:
- 帕金森病 (PD) 是全球普遍存在的一种神经退行性疾病.
- 目前的诊断和治疗策略需要改进.
- 早期发现PD对于有效管理至关重要.
研究的目的:
- 审查帕金森病生物标志物的最新进展.
- 总结神经成像技术的进展.
- 突出了PD的诊断潜力和未来研究方向.
主要方法:
- 脑脊液生物标志物分析
- 血液和外围组织生物标志物的研究.
- 神经成像技术包括MRI,SPECT和PET.
主要成果:
- 脊髓液,血液和组织中的生物标志物显示出早期发现病情的潜力.
- 神经成像提供了神经退化和大脑变化的详细可视化.
- 最近的进展为PD提供了更好的诊断能力.
结论:
- 生物标志物和神经影像是诊断病症的重要工具.
- 这些领域的进一步研究可以带来更好的治疗策略.
- 结合生物标志物和神经成像的综合方法是未来PD研究的关键.
相关概念视频
Neural Regulation
39.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.9K
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666


